BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32184027)

  • 1. Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study.
    Tsujita K; Deguchi H; Uda A; Sugano K
    J Cardiol; 2020 Jul; 76(1):51-57. PubMed ID: 32184027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy.
    Yang S; Shi L
    Inflammopharmacology; 2024 Jun; 32(3):1999-2006. PubMed ID: 38642222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
    Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
    BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar Effect of Vonoprazan and Oral Proton Pump Inhibitors for Preventing Rebleeding in Cases of Upper Gastrointestinal Bleeding.
    Abe H; Tarasawa K; Hatta W; Koike T; Sato I; Ono Y; Ogata Y; Saito M; Jin X; Kanno T; Uno K; Asano N; Imatani A; Fujimori K; Fushimi K; Masamune A
    Intern Med; 2024 Apr; 63(7):911-918. PubMed ID: 37558479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort Study.
    Lee SR; Ahn HJ; Choi EK; Park SH; Han KD; Oh S; Lip GYH
    Clin Gastroenterol Hepatol; 2024 May; 22(5):981-993.e11. PubMed ID: 38184099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment.
    Abe H; Hatta W; Ogata Y; Koike T; Saito M; Jin X; Nakagawa K; Kanno T; Uno K; Asano N; Imatani A; Nakamura T; Nakaya N; Tarasawa K; Fujimori K; Fushimi K; Masamune A
    J Gastroenterol; 2021 Jul; 56(7):640-650. PubMed ID: 33876324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
    Jensen BES; Hansen JM; Larsen KS; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1118-1125. PubMed ID: 28678044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Acid Suppression With Vonoprazan vs Proton Pump Inhibitors Does Not Have Higher Association With Clostridioides difficile Infection.
    Watanabe K; Shimodaira Y; Takahashi S; Fukuda S; Koizumi S; Matsuhashi T; Iijima K
    Am J Gastroenterol; 2021 Aug; 116(8):1632-1637. PubMed ID: 33989224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan.
    Ishii M; Kawai T; Tsujita K; Igarashi A; Suzuki M; Deguchi H; Fernandez J
    Circ J; 2023 Jan; 87(2):348-359. PubMed ID: 36002313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
    Lin KJ; Hernández-Díaz S; García Rodríguez LA
    Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
    Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
    Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper Gastrointestinal Bleeding in Japanese Patients Prescribed Antithrombotic Drugs: Differences in Trends over Time.
    Yamaguchi D; Sakata Y; Tsuruoka N; Shimoda R; Higuchi T; Sakata H; Fujimoto K; Iwakiri R
    Hepatogastroenterology; 2014 Jun; 61(132):1055-62. PubMed ID: 26158165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study.
    Kambara H; Hosohata K; Nakatsuji T; Ueno S; Oyama S; Inada A; Niinomi I; Wakabayashi T; Iwanaga K
    Pharmazie; 2020 Oct; 75(10):527-530. PubMed ID: 33305731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy.
    Shaukat A; Waheed S; Alexander E; Washko D; Dawn B; Olyaee M; Gupta K
    J Dig Dis; 2018 Feb; 19(2):66-73. PubMed ID: 29314627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.
    Huang KW; Luo JC; Leu HB; Huang CC; Hou MC; Chen TS; Lu CL; Lin HC; Lee FY; Chang FY
    J Chin Med Assoc; 2013 Jan; 76(1):9-14. PubMed ID: 23331775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.